Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS

    Ola Khorshid, Safaa M. Ramadan
    e2015058
    2015-10-16
    https://doi.org/10.4084/mjhid.2015.058
    2206
    PDF: 1120
    HTML: 1263
  • Chemotherapy-colchicine interaction in a child with Familial Mediterranean Fever and Hodgkin Lymphoma

    Karin Petra Sabine Langenberg-Ververgaert, Ronald M. Laxer, Angela S. Punnett, Lee L Dupuis, Yaron Finkelstein, Oussama Abla
    e2018019
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.019
    2977
    PDF: 908
    HTML: 477
  • A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.

    Mickey Sachdeva, Haifaa Abdulhaq
    e2013022
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.022
    1457
    PDF: 979
    HTML: 1680
    Figure 1: 215
  • PROTECTIVE ROLE OF SYLIMARIN ON METHOTREXATE INDUCED HEPATO-NEPHROTOXICITY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Adel Abd Elhaleim Hagag
    e2016043
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.043
    3782
    PDF: 1098
    HTML: 1622
  • UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN FOLLICULAR LYMPHOMAS

    Mónica Cabrero, Alba Redondo, Alejandro Martin, Dolores Caballero
    e2012074
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.074
    2253
    PDF: 793
    HTML: 1115
  • RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM

    Ugo Testa, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2023062
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.062
    1391
    PDF: 1138
    HTML: 267
  • Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

    Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, Massimo Negrini, Eleonora Volta, Melissa Dabusti, Maria Ciccone, Antonio Urso, Michele Laudisi, Antonio Cuneo
    e2019057
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.057
    1682
    PDF: 1018
    HTML: 307
  • Simultaneous dual pathology in lymph node

    Prakas Kumar Mandal, Supriyo Sarkar, Malay Kumar Ghosh, Maitreyee Bhattacharyya
    e2014036
    2014-05-31
    https://doi.org/10.4084/mjhid.2014.036
    1733
    PDF: 757
    HTML: 7850
    Simultaneous dual pathology in lymph node: 211
    Simultaneous dual pathology in lymph node: 221
    Simultaneous dual pathology in lymph node: 183
    Simultaneous dual pathology in lymph node: 227
    Simultaneous dual pathology in lymph node: 219
  • FDG-PET SCAN: A NEW PARADIGM FOR FOLLICULAR LYMPHOMA MANAGEMENT.

    Andrea Gallamini, Anna Borra
    e2017029
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.029
    3421
    PDF: 1333
    HTML: 2371
  • Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients

    Alfredo Marzano, Andrea Marengo, Michela di Fonzo, Antonella Ferrari, Bruno Monarca, Gianfranco delle Fave, Massimo Marignani
    e2010035
    2010-12-13
    https://doi.org/10.4084/mjhid.2010.035
    1048
    PDF: 602
    HTML: 2231
    Cover Letter: 231
  • Simultaneous presentation of Hemophagocytic Lymphohistiocytosis and Classical Hodgkin's Lymphoma in a patient with underlying germline homozygous STXBP2 Mutation.

    Dr Shilpa Gupta, Dr Amrita Rajendran , Dr Akanksha Chichra , Dr Ayubali Qureshi
    e2026043
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.043
    341
    PDF: 233
    HTML: 83
  • BENDAMUSTINE AND RITUXIMAB AS FIRST LINE TREATMENT IN SPLENIC MARGINAL ZONE LYMPHOMAS of ELDERLY PATIENTS.

    Roberto Castelli
    e2016030
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.030
    5918
    PDF: 1035
    HTML: 2328
  • Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin

    Caterina Giovanna Valentini, Valentina Bozzoli, Anna Rita Larici, Luigi Maria Larocca, Giovanni Delogu, Giuseppe Leone, Livio Pagano
    e2012040
    2012-06-18
    https://doi.org/10.4084/mjhid.2012.040
    2126
    PDF: 721
    HTML: 19635
101 - 113 of 113 items << < 1 2 3 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.